Dr. Westbrook is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 East Lake Front Drive
Beverly Shores, IN 46301
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1983 - 1985
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983- University of ChicagoResidency, Internal Medicine, 1978 - 1981
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1978
Certifications & Licensure
IN State Medical License 2006 - 2025
MA State Medical License 2004 - 2025
PA State Medical License 2011 - 2024
IL State Medical License 1979 - 2014- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 2 citationsIn a resource-poor country, mutation identification has the potential to reduce the cost of family management for hereditary nonpolyposis colorectal cancer.P A Goldberg, M V Madden, C Harocopos, R Felix, C Westbrook
Diseases of the Colon and Rectum. 1998-10-01 - 16 citationsUse of a CEPH meiotic breakpoint panel to refine the locus of limb- girdle muscular dystrophy type 1A (LGMD1A) to a 2-Mb interval on 5q31Lucia Bartoloni, Stephen K. Horrigan, Kristi D. Viles, James M. Gilchrist, Jeffery Stajich
Genomics. 1998-12-01 - 62 citationsA novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31Zhenbo Hu, Ignatius Gomes, Stephen K. Horrigan, Jelena Kravarusic, Brenton G. Mar
Oncogene. 2001-10-18
Press Mentions
Opportunity, Not Obligation: An Interview with Wendy Stock, MDDecember 1st, 2020- Can You Answer This Cancer Question, Doc?November 23rd, 2020
Grant Support
- Tumor Suppressor Genes In Secondary MDS And AMLNational Cancer Institute1997–2002
- Breast Cancer Metastases Genes Identified By CDNA ArraysNational Cancer Institute2000–2001
- Deletions Of Chromosome 5 And Myeloid MalignanciesNational Cancer Institute1997–2000
- Chromosome 8p Tumor Suppressor GeneNational Cancer Institute1995–1998
- Identification Of Antileukemia Genes By Physical Mapping MethodsNational Cancer Institute1992–1996
- Chromosome 8p Tumor Suppressor GeneNational Cancer Institute1995
- Gastric, Pancreatic &Colon Tumor Suppressor Gene On 8pNational Cancer Institute1993
- Second International Workshop On Human Chromosome 5National Human Genome Research Institute1992
- Molecular Genetic Findings In Colorectal CancerNational Cancer Institute1991–1992
- Molecular Genetics Of Chromosome Nine TranslocationsNational Cancer Institute1987–1991
- Macrorestriction Mapping Applied To Chromosome 5qNational Human Genome Research Institute1990
- Macrorestriction Mapping Applied To Chromosome 5qNational Institute Of General Medical Sciences1988–1989
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
